LBP

Pharma vs food: regulatory variations

Colette Shortt, Regulatory Specialist and Visiting Professor University of Ulster, spoke about the regulatory framework for food supplements and Live Biotherapeutic products.

How Biose Industrie Makes the Difference in LBP Process Development & GMP Production

MicrobiomePost discussed with Claire Derlot, Head of Programs at Biose Industrie, the GMP challenges when you have to go from bacteria to a drug.

Proge Farm receives authorisation for the gynaecological drug containing its Lactobacillus plantarum p 17630 in the EU

Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top